产品名称 | NebuSelect™ Recombinant Biotinylated Human LILRB4/CD85k/ILT3, Avi-His-tag |
---|---|
目录号 | NBL-242339 |
别名 | LILRB4/CD85k/ILT3; HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | AAH26309 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242339-100ug | 100ug | Inquire | Inquire | |
NBL-242339-1mg | 1mg | Inquire | Inquire | |
NBL-242339-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human LILRB4/CD85k/ILT3, Avi-His-tag
Catalog#:
NBL-242339
Description:
NebuSelect™ Recombinant Biotinylated Human LILRB4/CD85k/ILT3, Avi-His-tag(Cat#NBL-242339) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Gln22-His257.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 28.6 kDa. Due to glycosylation, the protein migrates to 38-42 kDa based on Bis-Tris PAGE result.
Target Name:
LILRB4/CD85k/ILT3; HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Target Information:
LILRB4,also known as CD85k and LIR-5, ILT3,- is an approximately 60 kDa transmembrane glycoprotein that negatively regulates immune cell activation. Mature human ILT3 consists of a 238 amino acid (aa) extracellular domain with two Ig-like domains, a 21 aa transmembrane segment, and a 168 aa cytoplasmic domain with 3 immunoreceptor tyrosine-based inhibitory motifs (ITIM).LILRB4 is receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.